SCHEMBL3688959

SCHEMBL3688959

COC(=O)c1cccc([C@H]2CCCN(C(=O)[C@H]3COc4ccccc4O3)C2)c1.OCc1cccc([C@H]2CCCN(C[C@H]3COc4ccccc4O3)C2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KMT2A Q03164 3/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ NPC1 O15118 1/20 0.44
▸ RAB9A P51151 1/20 0.44
▸ PDE2A O00408 2/20 0.43
▸ DRD2 P14416 2/20 0.43
▸ DRD3 P35462 1/20 0.43
▸ ALDH1A1 P00352 2/20 0.42
▸ HPGD P15428 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ AIMP2 Q13155 1/20 0.41
▸ ADRA2A P08913 2/20 0.40
▸ ADRA2B P18089 2/20 0.40
▸ ADRA2C P18825 2/20 0.40
▸ TSHR P16473 2/20 0.39
▸ MAPT P10636 2/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ ADRA1D P25100 1/20 0.39
▸ ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3688957 1.00 KMT2A (0.44) KMT2AMEN1NPC1RAB9APDE2A
SCHEMBL3040030 0.87 KMT2A (0.56) KMT2AMEN1NPC1RAB9APDE2A
SCHEMBL3040025 0.87 KMT2A (0.56) KMT2AMEN1NPC1RAB9APDE2A
SCHEMBL3040028 0.87 KMT2A (0.56) KMT2AMEN1NPC1RAB9APDE2A
SCHEMBL30495409 0.83 DRD2 (0.56) DRD2DRD3ADRA2AADRA2BADRA2C
SCHEMBL3032022 0.83 DRD2 (0.56) DRD2DRD3ADRA2AADRA2BADRA2C
SCHEMBL3032026 0.83 DRD2 (0.56) DRD2DRD3ADRA2AADRA2BADRA2C
SCHEMBL3032025 0.83 DRD2 (0.56) DRD2DRD3ADRA2AADRA2BADRA2C
SCHEMBL31137843 0.83 DRD2 (0.56) DRD2DRD3ADRA2AADRA2BADRA2C
SCHEMBL567588 0.75 ALDH1A1 (0.58) KMT2AMEN1NPC1RAB9APDE2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2176252-A1 2, 3-DIHYDROBENZO[1, 4]DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES ORION CORPORATION (FI) 2010-04-21 — — EP disclosed
WO-2009013390-A1 2, 3-DIHYDROBENZO[1, 4] DIOXIN-2-YLMETHYL DERIVATIVES AS ALPHA2C ANTAGONISTS FOR USE IN THE TREATMENT OF PERIPHERIC AND CENTRAL NERVOUS SYSTEME DISEASES ORION CORPORATION (FI) 2009-01-29 — — WO disclosed
Send feedback